[1]中华人民共和国卫生部疾病预防控制局,中华人民共和国卫生部医政司,中国疾病预防控制中心.中国结核病防治规划实施工作指南(2008年版).北京:中国协和医科大学出版社,2009:1.[2]Huovinen P. Resistance to trimethoprim-sulfamethoxazole.Clin Infect Dis, 2001, 32(11): 1608-1614.[3]Young LS. Reconsidering some approved antimicrobial agents for tuberculosis. Antimicrob Agents Chemother,2009,53(11):4577-4579.[4]Forgacs P, Wengenack NL, Hall L,et al.Tuberculosis and trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother, 2009,53(11):4789-4793.[5]Franzblau S,Witzig R, McLaughlin J, et al. Rapid, low-technology MIC determination with clinical M. tuberculosis isolates by using the Microplate Alamar Blue Assay. J Clin Microbiol, 1998, 36(2):362-366.[6]Lewis RE, Diekema DJ, Messer SA, et al. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species.J Antimicrob Chemother, 2002,49(2):345-351.[7]Ge F, Zeng F, Liu S, et al. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis. J Med Microbiol, 2010,59(5):567-572.[8]Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med, 2012,366(23):2161-2170.[9]Huang TS, Kunin CM, Yan BS, et al. Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan.J Antimicrob Chemother, 2012,67(3):633-637.[10]García-Cobos S, Campos J, Cercenado E, et al. Antibiotic resistance in Haemophilus influenzae decreased, except for beta-lactamase-negative amoxicillin-resistant isolates, in parallel with community antibiotic consumption in Spain from 1997 to 2007. Antimicrob Agents Chemother, 2008,52(8):2760-2766.[11]Richter SS, Heilmann KP, Dohrn CL, et al. Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.Antimicrob Agents Chemother, 2011, 55(9):4154-4160.[12]马玙, 朱莉贞, 潘毓萱. 结核病. 北京:人民卫生出版社,2006: 507-531.[13]Vilchèze C, Jacobs WR Jr.The combination of sulfametho-xazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2012,56(10):5142-5148.[14]Alsaad N, van Altena R, Pranger AD, et al.Evaluation of co-trimoxazole in treatment of multidrug-resistant tuberculosis. Eur Respir J, 2012 [Epub ahead of print].[15]Leonard B, Coronel J, Siedner M, et al. Inter- and intra-assay reproducibility of microplate Alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol, 2008, 46(10):3526-3529.[16]Yu X, Jiang G, Li H,et al. Rifampin stability in 7H9 broth and Lowenstein-Jensen medium. J Clin Microbiol, 2011,49(3):784-789.[17]黄海荣,于霞,姜广路,等. 利奈唑胺对分枝杆菌体外抑菌作用的初步研究.中华结核和呼吸杂志,2011,34(8):575-578.[18]陆宇,郑梅琴,王彬,等.氯法齐明抗结核分枝杆菌的体内外活性研究.中华结核和呼吸杂志,2008,31(10):752-501. |